244 related articles for article (PubMed ID: 1124051)
1. [Radiation late damage of the thoracic marrow after irradiation in the thoracic region (author's transl)].
Busse O; Wieland C; Egge M
Med Klin; 1975 Feb; 70(9):385-91. PubMed ID: 1124051
[TBL] [Abstract][Full Text] [Related]
2. [Radiotherapy of lymphogranulomatosis--relations between radiomyelitis and oncogenic alteration of the spinal marrow (author's transl)].
Schulz U; Busch M
Strahlentherapie; 1977 Oct; 153(10):655-9. PubMed ID: 919000
[TBL] [Abstract][Full Text] [Related]
3. [Radiotherapy techniques of the mediastinum (author's transl)].
Felci U
Radiol Med; 1977 May; 63(5):407-16. PubMed ID: 594423
[TBL] [Abstract][Full Text] [Related]
4. [Radiation pneumonitis and radiation fibrosis following systemic irradiation of thoracic lymph nodes in Hodgkin's disease].
Castrup W; Wannenmacher M; Blömer M
Strahlentherapie; 1976 Jul; 152(1):15-21. PubMed ID: 951715
[TBL] [Abstract][Full Text] [Related]
5. [Radiation pneumonitis as a complication in the aftertreatment of bronchial and mediastinal tumour patients (author's transl)].
Drescher W; Schumann E
Radiobiol Radiother (Berl); 1978 Jun; 19(3):282-5. PubMed ID: 725011
[No Abstract] [Full Text] [Related]
6. [Application of the NSD-concept for the ascertainment of tolerance doses in the region of the lung (author's transl)].
Herrmann Th; Voigtmann L; Ehrhardt M; Eberhardt HJ; Strietzel M
Strahlentherapie; 1979 Jan; 155(1):10-4. PubMed ID: 760269
[TBL] [Abstract][Full Text] [Related]
7. [Comparative post-radiological studies of bone marrow following 200 kV and tele-cobalt therapy].
Choné B
Strahlentherapie Sonderb; 1965; 61():277-87. PubMed ID: 5890041
[No Abstract] [Full Text] [Related]
8. [The appearance of radiation-induced lesions after radiotherapy for Hodgkin's disease of the mediastinum and lungs (author's transl)].
Zomer-drozda J
Pol Przegl Radiol Med Nukl; 1976; 40(4):247-50. PubMed ID: 980933
[No Abstract] [Full Text] [Related]
9. [Late chronic serous-constrictive pericarditis after radiotherapy of Hodgkin's disease].
Wehr M
Internist (Berl); 1981 Dec; 22(12):749-53. PubMed ID: 7033166
[No Abstract] [Full Text] [Related]
10. [Cervical radiation myelopathy with spastic paraparesis of the arms. Case report and a review of the literature].
Berlit P; Härle M; Johann A
Nervenarzt; 1987 Jan; 58(1):40-6. PubMed ID: 3561614
[TBL] [Abstract][Full Text] [Related]
11. [Radiation myelopathy].
Gänshirt H
Nervenarzt; 1975 Oct; 46(10):562-8. PubMed ID: 172813
[No Abstract] [Full Text] [Related]
12. Dose distribution with high voltage irradiation of mediastinal Hodgkin's diseases.
Gyenes G
Strahlentherapie; 1972 Nov; 144(5):591-4. PubMed ID: 4630435
[No Abstract] [Full Text] [Related]
13. Bone marrow damage following total nodal irradiation in Hodgkin's disease patients.
Cionini L
Br J Radiol; 1973 Jan; 46(541):67-8. PubMed ID: 4683333
[No Abstract] [Full Text] [Related]
14. [Radiation myelopathies (author's transl)].
Durkovský J
Cesk Radiol; 1975 May; 29(3):173-8. PubMed ID: 1173567
[No Abstract] [Full Text] [Related]
15. [Paraplegia due to late damage of the spinal cord following radiotherapy].
Noetzel H; Weber M
Med Welt; 1974 Feb; 25(5):189-92. PubMed ID: 4814060
[No Abstract] [Full Text] [Related]
16. [Critical consideration of various irradiation methods in Hodgkin's disease].
Kärcher KH
Strahlentherapie; 1976 Feb; 151(2):176-82. PubMed ID: 1258088
[TBL] [Abstract][Full Text] [Related]
17. [Possibilities of radiation-dose reduction in the treatment of Hodgkin's disease. I. Exclusion of the mediastinum from the radiation field in primary high-cervical or infradiaphragmatic involvement and stage I or II (author's transl)].
Teillet E; Delbrück H; Bayle-Weisgerber C; Andrieu JM; Asselain B; Dana M; Bernard J
Dtsch Med Wochenschr; 1979 Sep; 104(39):1369-74. PubMed ID: 477568
[TBL] [Abstract][Full Text] [Related]
18. [Lumbar radiation myelopathy. Case report on localization of lumbar radiation sequelae].
Berlit P
Nervenarzt; 1985 Apr; 56(4):206-9. PubMed ID: 4000318
[TBL] [Abstract][Full Text] [Related]
19. Phase I study of 90Y-labeled B72.3 intraperitoneal administration in patients with ovarian cancer: effect of dose and EDTA coadministration on pharmacokinetics and toxicity.
Rosenblum MG; Verschraegen CF; Murray JL; Kudelka AP; Gano J; Cheung L; Kavanagh JJ
Clin Cancer Res; 1999 May; 5(5):953-61. PubMed ID: 10353726
[TBL] [Abstract][Full Text] [Related]
20. Magnetic resonance (MR) evaluation of bone marrow in vertebral bodies.
Orlandini GE; Ruggiero L; Gulisano M; Ruggiero M; Villari N; Casamassima F
Arch Ital Anat Embriol; 1991; 96(2):93-100. PubMed ID: 1805708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
